The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting

Tumor angiogenesis: therapeutic implications

Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187 · see citing works

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,771 · see citing works

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565 · see citing works

Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen

Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,988 · see citing works

Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid

Senger, D. R., Galli, S. J., Dvořàk, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,969 · see citing works

Angiogenesis.

Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,651 · see citing works

Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells

Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,269 · see citing works

Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF

Keck, P. J., Hauser, S. D., Krivi, G. G., Sanzo, K., Warren, T. G., Feder, J., & Connolly, D. T. (1989) · Science · doi:10.1126/science.2479987 · Cited by 2,058 · see citing works

The codependence of angiogenesis and chronic inflammation

Jackson, J. R., Seed, M. P., Kircher, C. H., Willoughby, D. A., & Winkler, J. D. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.6.9194526 · Cited by 690 · see citing works

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.

Vasey, P. A., Kaye, S. B., Morrison, R. A., Twelves, C. J., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., et al. (1999) · PubMed · Cited by 689 · see citing works

Tumoritropic and lymphotropic principles of macromolecular drugs.

Maeda, H., & Matsumura, Y. (1989) · PubMed · Cited by 579 · see citing works

Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo

Maeda, H., Seymour, L. W., & Miyamoto, Y. (1992) · Bioconjugate Chemistry · doi:10.1021/bc00017a001 · Cited by 563 · see citing works

Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal Tissues

Noguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T., & Maeda, H. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00563.x · Cited by 470 · see citing works

Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer

Gallo, O., Fini-Storchi, I., Vergari, W. A., Masini, E., Morbidelli, L., Ziche, M., & Franchi, A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.8.587 · Cited by 427 · see citing works

Hereditary nonpolyposis colorectal cancer (lynch syndromes I and II). I. Clinical description of resource

Lynch, H. T., Kimberling, W. J., Albano, W. A., Lynch, J. F., Biscone, K. A., Schuelke, G. S., Sandberg, A. A., Lipkin, M., Deschner, E. E., Mikol, Y. B., et al. (1985) · Cancer · doi:10.1002/1097-0142(19850815)56:4 · Cited by 402 · see citing works

Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report

Konno, T., Maeda, H., Iwai, K., Tashiro, S., Maki, S., Morinaga, T., Mochinaga, M., Hiraoka, T., & Yokoyama, I. (1983) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(83)90028-7 · Cited by 342 · see citing works

Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier

Seymour, L. W., Miyamoto, Y., Maeda, H., Brereton, M., Strohalm, J., Ulbrich, K., & Duncan, R. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(94)00514-6 · Cited by 337 · see citing works

Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image.

Iwai, K., Maeda, H., & Konno, T. (1984) · PubMed · Cited by 284 · see citing works

A New Approach to Cancer Chemotherapy: Selective Enhancement of Tumor Blood Flow With Angiotensin II 2 3

Suzuki, M., Hori, K., Abe, I., Saito, S., & Sato, H. (1981) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/67.3.663 · Cited by 268 · see citing works

Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121.

Asano, M., Yukita, A., Matsumoto, T., et al. (1995) · PubMed · Cited by 260 · see citing works

Inactivation of .alpha.1-proteinase inhibitor by peroxynitrite

Moreno, J. J., & Pryor, W. A. (1992) · Chemical Research in Toxicology · doi:10.1021/tx00027a017 · Cited by 250 · see citing works

Conjugation of poly(styrene-co-maleic acid) derivatives to the antitumor protein neocarzinostatin: pronounced improvements in pharmacological properties

Maeda, H., Ueda, M., Morinaga, T., & Matsumoto, T. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00382a012 · Cited by 225 · see citing works

Activation of Human Neutrophil Procollagenase by Nitrogen Dioxide and Peroxynitrite: A Novel Mechanism for Procollagenase Activation Involving Nitric Oxide

Okamoto, T., Akaike, T., Nagano, T., Miyajima, S., Suga, M., Ando, M., Ichimori, K., & Maeda, H. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0127 · Cited by 224 · see citing works

Enhanced Vascular Permeability in Solid Tumor Is Mediated by Nitric Oxide and Inhibited by Both New Nitric Oxide Scavenger and Nitric Oxide Synthase Inhibitor

Maeda, H., Noguchi, Y., Sato, K., & Akaike, T. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02362.x · Cited by 221 · see citing works

SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy

Maeda, H. (1991) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(91)90040-j · Cited by 214 · see citing works

Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger.

Wu, J., Akaike, T., & Maeda, H. (1998) · PubMed · Cited by 212 · see citing works

Microvascular architecture of experimental colon tumors in the rat.

Skinner, S. A., Tutton, P. J. M., & O’Brien, P. E. (1990) · PubMed · Cited by 179 · see citing works

Involvement of the Kinin‐generating Cascade in Enhanced Vascular Permeability in Tumor Tissue

Matsumura, Y., Kimura, M., Yamamoto, T., & Maeda, H. (1988) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1988.tb01563.x · Cited by 163 · see citing works

A LIPOPHILIC DERIVATIVE OF NEOCARZINOSTATIN A Polymer Conjugation of an Antitumor Protein Antibiotic*

MAEDA, H., Takeshita, J., & Kanamaru, R. (1979) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1979.tb01730.x · Cited by 157 · see citing works

Enhanced Vascular Permeability in Solid Tumor Involving Peroxynitrite and Matrix Metalloproteinases

Wu, J., Akaike, T., Hayashida, K., Okamoto, T., Okuyama, A., & Maeda, H. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01114.x · Cited by 152 · see citing works

Purification and identification of [hydroxyprolyl3]bradykinin in ascitic fluid from a patient with gastric cancer.

Maeda, H., Matsumura, Y., & Kato, H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37555-0 · Cited by 128 · see citing works

Mechanisms of localization of gallium-67 in tumors

Larson, S. M. (1978) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(78)80028-2 · Cited by 126 · see citing works

Doxorubicin-polymer conjugates: further demonstration of the concept of enhanced permeability and retention.

Muggia, F. M. (1999) · PubMed · Cited by 122 · see citing works

Microvessel quantification and its possible relation with liver metastasis in colorectal cancer

Tomisaki, S., Ohno, S., Ichiyoshi, Y., Kuwano, H., Maehara, Y., & Sugimachi, K. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960415)77:8 · Cited by 118 · see citing works

Tailor-making of protein drugs by polymer conjugation for tumor targeting: A brief review on smancs

Maeda, H., Matsumoto, T., Konno, T., Iwai, K., & Ueda, M. (1984) · Journal of Protein Chemistry · doi:10.1007/bf01040499 · Cited by 115 · see citing works

Kinin‐generating Cascade in Advanced Cancer Patients and in vitro Study

Matsumura, Y., Maruo, K., Kimura, M., Yamamoto, T., Konno, T., & Maeda, H. (1991) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1991.tb01910.x · Cited by 104 · see citing works

Conditioned Medium from Mouse Sarcoma 180 Cells Contains Vascular Endothelial Growth Factor

Rosenthal, R. A., Megyesi, J. F., Henzel, W. J., Ferrara, N., & Folkman, J. (1990) · Growth Factors · doi:10.3109/08977199009011010 · Cited by 100 · see citing works

Augmentation of tumour delivery of macromolecular drugs with reduced bone marrow delivery by elevating blood pressure

Li, C. J., Miyamoto, Y., Kojima, Y., & Maeda, H. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.179 · Cited by 96 · see citing works

Effects of steroids and nonsteroid anti-inflammatory agents on vascular permeability in a rat glioma model

Reichman, H. R., Farrell, C. L., & Maestro, R. F. D. (1986) · Journal of neurosurgery · doi:10.3171/jns.1986.65.2.0233 · Cited by 92 · see citing works

Human Matrix Metalloprotease Activation by Insults of Bacterial Infection Involving Proteases and Free Radicals

Maeda, H., Okamoto, T., & Akaike, T. (1998) · Biological Chemistry · doi:10.1515/bchm.1998.379.2.193 · Cited by 88 · see citing works

Kallikrein–kinin in infection and cancer

Maeda, H., Wu, J., Okamoto, T., Maruo, K., & Akaike, T. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00104-6 · Cited by 83 · see citing works

Targeting chemotherapy for hepatoma: Arterial administration of anticancer drugs dissolved in lipiodol

Konno, T. (1992) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80063-2 · Cited by 74 · see citing works

Is There a Role for Nitric Oxide in Tumor Angiogenesis?

García‐Cardeña, G., & Folkman, J. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.8.560 · Cited by 61 · see citing works

Involvement of Bradykinin Generation in Intravascular Dissemination ofVibrio vulnificusand Prevention of Invasion by a Bradykinin Antagonist

Maruo, K., Akaike, T., Ono, T., & Maeda, H. (1998) · Infection and Immunity · doi:10.1128/iai.66.2.866-869.1998 · Cited by 57 · see citing works

Tumor targeting by arterial administration of lipids: rabbit model with VX2 carcinoma in the liver.

Iwai, K., Maeda, H., Konno, T., et al. (1987) · PubMed · Cited by 49 · see citing works

Bradykinin Generation Triggered by Pseudomonas Proteases Facilitates Invasion of the Systemic Circulation by Pseudomonas aeruginosa

Sakata, Y., Akaike, T., Suga, M., et al. (1996) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1996.tb01088.x · Cited by 48 · see citing works

Medial regression and its functional significance in tumor-supplying host arteries. A morphometric study of hepatic arteries in human livers with hepatocellular carcinoma

Suzuki, M., Takahashi, T., & Sato, T. (1987) · Cancer · doi:10.1002/1097-0142(19870201)59:3 · Cited by 47 · see citing works

Tumor‐selective Blood Flow Decrease Induced by an Angiotensin Converting Enzyme Inhibitor, Temocapril Hydrochloride

Hori, K., Saito, S., Takahashi, H., Sato, H., Maeda, H., & Sato, Y. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00940.x · Cited by 45 · see citing works

Tumor-targeted chemotherapy with SMANCS in lipiodol for renal cell carcinoma: longer survival with larger size tumors

Tsuchiya, K., Uchida, T., Kobayashi, M., et al. (2000) · Urology · doi:10.1016/s0090-4295(99)00537-3 · Cited by 43 · see citing works

Metamorphosis of Neocarzinostatin to SMANCS: Chemistry, Biology, Pharmacology, and Clinical Effect of the First Prototype Anticancer Polymer Therapeutic

Maeda, H., & Konno, T. (1997) · Springer eBooks · doi:10.1007/978-4-431-66914-2_12 · Cited by 35 · see citing works

Drug Targeting in Cancer Therapy: The Magic Bullet, What Next?

Duncan, R., Connors, T. A., & Meada, H. (1996) · Journal of drug targeting · doi:10.3109/10611869608996823 · Cited by 31 · see citing works

Drug Targeting in Cancer Therapy

Poste, G. H. (1984) · Springer eBooks · doi:10.1007/978-1-4684-4862-7_25 · Cited by 28 · see citing works

Polymer Conjugation to Cu,Zn-SOD and Suppression of Hydroxyl Radical Generation on Exposure to H2O2: Improved Stability of SOD in Vitro and in Vivo

Kojima, Y., Akaike, T., Sato, K., et al. (1996) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391159601100301 · Cited by 26 · see citing works

Targeting Chemotherapy of Hepatocellular Carcinoma

Konno, T., & Maeda, H. (1987) · Springer eBooks · doi:10.1007/978-4-431-68349-0_27 · Cited by 22 · see citing works

Untitled work

Bryan (1984) · doi:10.1002/1097-0142(19841201)54:11

Factors affecting the clearance and biodistribution of polymeric nanoparticles

Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699 · see citing works

The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo

Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376 · see citing works

Engineered Nanoparticles for Drug Delivery in Cancer Therapy

Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164 · see citing works

The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application

Wu, J. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080771 · Cited by 1,030 · see citing works

Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery

Rapoport, N. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.009 · Cited by 1,002 · see citing works

Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?

Kobayashi, H., Watanabe, R., & Choyke, P. L. (2014) · Theranostics · doi:10.7150/thno.7193 · Cited by 996 · see citing works

Advances in polymeric micelles for drug delivery and tumor targeting

Kedar, U., Phutane, P., Shidhaye, S., & Kadam, V. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.05.005 · Cited by 791 · see citing works

Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers

Fang, J., Islam, W., & Maeda, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.005 · Cited by 757 · see citing works

A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics

Steichen, S. D., Caldorera-Moore, M., & Peppas, N. A. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.12.006 · Cited by 751 · see citing works

Pharmacokinetic aspects of retinal drug delivery

del Amo, E. M., Rimpelä, A.-K., Heikkinen, E., Kari, O. K., Ramsay, E., Lajunen, T., Schmitt, M., Pelkonen, L., Bhattacharya, M., Richardson, D., et al. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.12.001 · Cited by 693 · see citing works

Multifunctional and stimuli-sensitive pharmaceutical nanocarriers

Torchilin, V. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.026 · Cited by 583 · see citing works

Mechanisms of drug release in nanotherapeutic delivery systems

Wong, P. T., & Choi, S. K. (2015) · Chemical Reviews · doi:10.1021/cr5004634 · Cited by 507 · see citing works

Polymeric nanomedicine for cancer therapy

Park, J. H., Lee, S., Kim, J.-H., Park, K., Kim, K., & Kwon, I. C. (2008) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.09.003 · Cited by 506 · see citing works

Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats

Uchino, H., Matsumura, Y., Negishi, T., Koizumi, F., Hayashi, T., Honda, T., Nishiyama, N., Kataoka, K., Naito, S., & Kakizoe, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602772 · Cited by 430 · see citing works

A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours

Plummer, R., Wilson, R. H., Calvert, H., Boddy, A. V., Griffin, M., Sludden, J., Tilby, M. J., Eatock, M., Pearson, D. G., Ottley, C. J., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.6 · Cited by 390 · see citing works

Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor

Phua, S. Z. F., Yang, G., Lim, W. Q., Verma, A., Chen, H., Thanabalu, T., & Zhao, Y. (2019) · ACS Nano · doi:10.1021/acsnano.9b01087 · Cited by 375 · see citing works

Role of integrated cancer nanomedicine in overcoming drug resistance

Iyer, A. K., Singh, A., Ganta, S., & Amiji, M. M. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.012 · Cited by 343 · see citing works

Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy

Gindy, M. E., & Prud'homme, R. K. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902932908 · Cited by 298 · see citing works

Nanolipidic particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease

Smith, A., Giunta, B., Bickford, P. C., Fountain, M., Tan, J., & Shytle, R. D. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.01.012 · Cited by 280 · see citing works

Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicin

Kim, J. O., Kabanov, A. V., & Bronich, T. K. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.019 · Cited by 255 · see citing works

Biodegradable, polymeric nanoparticle delivery systems for cancer therapy

Pridgen, E. M., Langer, R., & Farokhzad, O. C. (2007) · Nanomedicine · doi:10.2217/17435889.2.5.669 · Cited by 249 · see citing works

Dual Intratumoral Redox/Enzyme-Responsive NO-Releasing Nanomedicine for the Specific, High-Efficacy, and Low-Toxic Cancer Therapy

Jia, X., Zhang, Y., Zou, Y., Wang, Y., Niu, D., He, Q., Huang, Z., Zhu, W., Tian, H., Shi, J., et al. (2018) · Advanced Materials · doi:10.1002/adma.201704490 · Cited by 232 · see citing works

Fibroblast Activation Protein-α as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review

Xin, L., Gao, J., Zheng, Z., Chen, Y., Lv, S., Zhao, Z., Yu, C., Yang, X., & Zhang, R. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.648187 · Cited by 203 · see citing works

The 35th Anniversary of the Discovery of EPR Effect: A New Wave of Nanomedicines for Tumor-Targeted Drug Delivery—Personal Remarks and Future Prospects

Maeda, H. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030229 · Cited by 167 · see citing works

β-Lapachone-containing PEG–PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells

Blanco, E., Bey, E. A., Dong, Y., Weinberg, B. D., Sutton, D. M., Boothman, D. A., & Gao, J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.014 · Cited by 165 · see citing works

Lipid nanoparticles for short interfering RNA delivery

Leung, A. K. K., Tam, Y. Y. C., & Cullis, P. R. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800148-6.00004-3 · Cited by 158 · see citing works

Influence of serum protein on polycarbonate-based copolymer micelles as a delivery system for a hydrophobic anti-cancer agent

Liu, J., Zeng, F., & Allen, C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.12.013 · Cited by 139 · see citing works

The Fluid Mechanics of Cancer and Its Therapy

Koumoutsakos, P., Pivkin, I., & Milde, F. (2013) · Annual Review of Fluid Mechanics · doi:10.1146/annurev-fluid-120710-101102 · Cited by 129 · see citing works

Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability

Watanabe, M., Kawano, K., Yokoyama, M., Opanasopit, P., Okano, T., & Maitani, Y. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.030 · Cited by 128 · see citing works

Polyethylene glycol: A promising approach for sustainable organic synthesis

Soni, J., Sahiba, N., Sethiya, A., & Agarwal, S. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.113766 · Cited by 107 · see citing works

Influence of protein corona and caveolae-mediated endocytosis on nanoparticle uptake and transcytosis

Ho, Y. T., Kamm, R. D., & Kah, J. C. Y. (2018) · Nanoscale · doi:10.1039/c8nr02393j · Cited by 102 · see citing works

Functional imaging of tumor vasculature using iodine and gadolinium-based nanoparticle contrast agents: A comparison of spectral micro-CT using energy integrating and photon counting detectors

Badea, C. T., Clark, D. P., Holbrook, M., Srivastava, M., Mowery, Y., & Ghaghada, K. B. (2019) · Physics in Medicine & Biology · doi:10.1088/1361-6560/ab03e2 · Cited by 74 · see citing works

Nanodelivery Systems for Nucleic Acid Therapeutics in Drug Resistant Tumors

Iyer, A. K., Duan, Z., & Amiji, M. M. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500024p · Cited by 55 · see citing works

NIR‐II Emissive Ru(II) Metallacycle Assisting Fluorescence Imaging and Cancer Therapy

Fan, Y., Li, C., Bai, S., Ma, X., Yang, J., Guan, X., & Sun, Y. (2022) · Small · doi:10.1002/smll.202201625 · Cited by 51 · see citing works

When near-infrared fluorescence meets supramolecular coordination complexes: Challenges and opportunities of metallacycles/metallacages in precision biomedicine

Xu, Y., Dou, Y., Li, Q., Ye, H., Li, Y., Qiu, S., Xiong, X., Li, J., & Sun, Y. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215320 · Cited by 39 · see citing works

Liposomal glutathione as a promising candidate for immunological rheumatoid arthritis therapy

Kadry, M. O. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02162 · Cited by 29 · see citing works

EGF-liposomes promote efficient EGFR targeting in xenograft colocarcinoma model

Zalba, S., Contreras, A. M., Merino, M., Navarro, I., de Ilarduya, C. T., Trocóniz, I. F., Koning, G., & Garrido, M. J. (2016) · Nanomedicine · doi:10.2217/nnm.15.208 · Cited by 26 · see citing works

Multispectral optoacoustic tomography (MSOT) for imaging the particle size-dependent intratumoral distribution of polymeric micelles

Cong, Z., Yang, F., Cao, L., Wen, H., Fu, T., Ma, S., Liu, C., Quan, L., & Liao, Y. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s185726 · Cited by 23 · see citing works

CPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds?

Brunetti, C., Anelli, L., Zagaria, A., Specchia, G., & Albano, F. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1369400 · Cited by 23 · see citing works

Pathophysiologic and Pharmacologic Considerations to Improve the Design and Application of Antibody–Drug Conjugates

Boghaert, E. R., Cox, M. C., & Vaidya, K. S. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-3236 · Cited by 17 · see citing works

Investigations of EPR Parameters of MgTiO3:Cr3+, SrTiO3:Cr3+, and SrTiO3:Mn4+ Crystals

Zhu, L., Wang, M., & Jianliang, D. (2011) · Applied Magnetic Resonance · doi:10.1007/s00723-011-0235-3 · Cited by 3 · see citing works

A V2+ion in GaAs studied by thermally detected EPR

Vasson, A. M., Labadz, A. F., Tebbal, N., et al. (1992) · Journal of Physics Condensed Matter · doi:10.1088/0953-8984/4/18/022 · Cited by 5 · see citing works

Point defects in ZnO: Electron paramagnetic resonance study

Vlasenko, L. S. (2009) · Physica B Condensed Matter · doi:10.1016/j.physb.2009.08.149 · Cited by 30 · see citing works

EPR investigation of two types of Syrian's natural zeolites

Soulayman, S., Mkami, H. E., & SMITH, G. M. (2004) · Journal of Physics and Chemistry of Solids · doi:10.1016/j.jpcs.2004.06.003 · Cited by 4 · see citing works

EPR study of some rare-earth ions (Dy3+, Tb3+, and Nd3+) in YBa2Cu3O6-compound

Gafurov, M. R., Ivanshin, V. A., Kurkin, I. N., et al. (2003) · Journal of Magnetic Resonance · doi:10.1016/s1090-7807(03)00002-8 · Cited by 30 · see citing works